Is there a role for stereotactic radiotherapy in the treatment of renal cell carcinoma?

Renal cell carcinoma (RCC) has traditionally been regarded as radioresistant tumor based on preclinical data and negative clinical trials using conventional fractionated radiotherapy. However, there is emerging evidence that radiotherapy delivered in few fractions with high single-fraction and total...

Descripción completa

Detalles Bibliográficos
Autores principales: Rühle, Alexander, Andratschke, Nicolaus, Siva, Shankar, Guckenberger, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630187/
https://www.ncbi.nlm.nih.gov/pubmed/31341985
http://dx.doi.org/10.1016/j.ctro.2019.04.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630187/
https://www.ncbi.nlm.nih.gov/pubmed/31341985
http://dx.doi.org/10.1016/j.ctro.2019.04.012

Ejemplares similares